George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIR.L Regulatory News (CIR)

  • There is currently no data for CIR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

14 Apr 2020 07:30

RNS Number : 5304J
Circassia Pharmaceuticals Plc
14 April 2020
 

Director/PDMR Shareholding

Oxford, UK - 14 April 2020: Circassia Pharmaceuticals plc ("Circassia" or "the Company"; LSE: CIR), a specialty biopharmaceutical company focused on respiratory disease, today announces that on 9 April 2020, Ian Johnson, Executive Chairman of Circassia purchased 200,000 Ordinary Shares at a price of 22.85 pence per share, Michael Roller, Chief Financial Officer purchased 200,000 Ordinary Shares at a price of 22.683 pence per share and Jonathan Emms, Chief Operating Officer of Circassia, purchased 300,000 Ordinary Shares at a price of 23.2 pence per share.

Following these purchases, Ian Johnson holds 200,000 Ordinary Shares (0.05% of the issued share capital of the Company), Michael Roller holds 200,000 Ordinary Shares (0.05% of the issued share capital of the Company) and Jonathan Emms holds 600,000 Ordinary Shares (0.16% of the issued share capital of the Company).

Contacts

Circassia Pharmaceuticals plc

Ian Johnson Executive Chairman

Michael Roller Chief Financial Officer

c/o FTI Consulting

 

 

Peel Hunt LLP (Nominated Adviser and Broker)

James Steel / Oliver Jackson

 

Tel: +44 (0)20 7418 8900

finnCap (Joint Broker)

Geoff Nash / Alice Lane

 

Tel: +44 (0) 20 7220 0500

Numis Securities (Joint Broker)

James Black / Duncan Monteith

 

Tel: +44 (0) 20 7260 1000

FTI Consulting

Simon Conway / Ciara Martin

Tel: +44 (0) 20 3727 1000

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

1. Ian Johnson

2. Michael Roller

3. Jonathan Emms

2.

Reason for the notification

a.

Position/status

1. Executive Chairman

2. Chief Financial Officer

3. Chief Operating Officer

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Circassia Pharmaceuticals plc

b.

LEI

2138006YAT138TOGA556

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary Shares of 0.08p each

 

 

GB00BJVD3B28

b.

Nature of the transaction

Purchase of Ordinary Shares

 

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

1. 22.85p

2. 22.683p

3. 23.2p

1. 200,000

2. 200,000

3. 300,000

d.

Aggregated information

· Aggregated volume

· Price

 

 

 

n/a

 

e.

Date of the transaction

2020-04-09

f.

Place of the transaction

London Stock Exchange, AIM

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHGLGDSCDBDGGS
Date   Source Headline
3rd Apr 201712:20 pmRNSResult of General Meeting on 3 April 2017
31st Mar 20177:00 amRNSTotal Voting Rights
29th Mar 20175:56 pmRNSHolding(s) in Company
17th Mar 20172:23 pmRNSPublication of a Prospectus
17th Mar 20177:00 amRNSCollaboration with AstraZeneca
28th Feb 20177:00 amRNSTotal Voting Rights Update
31st Jan 20177:00 amRNSTotal Voting Rights
9th Jan 20175:03 pmRNSBlock listing Interim Review
30th Dec 20167:00 amRNSTotal Voting Rights
16th Dec 20162:44 pmRNSDirectorate Change
30th Nov 20163:12 pmRNSTotal Voting Rights Update
8th Nov 20164:40 pmRNSSecond Price Monitoring Extn
8th Nov 20164:35 pmRNSPrice Monitoring Extension
31st Oct 20167:00 amRNSTotal Voting Rights
30th Sep 20167:00 amRNSTotal Voting Rights
27th Sep 20167:00 amRNSInterim Results
20th Sep 20169:59 amRNSHolding(s) in Company
2nd Sep 20164:35 pmRNSPrice Monitoring Extension
31st Aug 20169:00 amRNSTotal Voting Rights
1st Aug 20163:55 pmRNSHolding(s) in Company
29th Jul 20167:00 amRNSTotal Voting Rights
19th Jul 20164:40 pmRNSSecond Price Monitoring Extn
19th Jul 20164:35 pmRNSPrice Monitoring Extension
18th Jul 20165:58 pmRNSBLOCK LISTING SIX MONTHLY RETURN
18th Jul 20165:54 pmRNSTotal Voting Rights
15th Jul 201611:00 amRNSNotice of Results
22nd Jun 20163:51 pmRNSHolding(s) in Company
20th Jun 20164:40 pmRNSSecond Price Monitoring Extn
20th Jun 20164:35 pmRNSPrice Monitoring Extension
20th Jun 20167:00 amRNSTop-Line Results from Cat Allergy Phase III Study
1st Jun 20162:51 pmRNSHolding(s) in Company
31st May 20167:00 amRNSTotal Voting Rights
25th May 20167:00 amRNSGrass Registration Study Initiation
19th May 20163:33 pmRNSGrant of awards to Directors
19th May 20163:30 pmRNSAppointment of Broker
18th May 20165:28 pmRNSResult of AGM
11th May 20162:51 pmRNSHolding(s) in Company
29th Apr 20167:00 amRNSTotal Voting Rights
27th Apr 20165:02 pmRNSHolding(s) in Company
21st Apr 20164:39 pmRNSHolding(s) in Company
31st Mar 20167:00 amRNSTotal Voting Rights
22nd Mar 201611:47 amRNSPosting of Annual Report and Notice of AGM
11th Mar 20167:00 amRNSFull Year Results 2015
7th Mar 20163:21 pmRNSNotice of Results
29th Feb 20167:00 amRNSTotal Voting Rights
25th Feb 20165:03 pmRNSHolding(s) in Company
1st Feb 20167:00 amRNSTotal Voting Rights
15th Jan 20164:13 pmRNSDirector Declaration
8th Jan 20167:00 amRNSTR-1: Notification of Major Interest in Shares
31st Dec 20157:00 amRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.